Clinical Trial Update: Open-Label, Single- and Multiple-Dose Pharmacokinetic Study of Diazoxide Choline [Phase 1]

View source ↗

Summary

The clinical trial NCT00901823, an open-label Phase 1 pharmacokinetic study of diazoxide choline for hypertriglyceridemia, has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia

Drugs mentioned

• diazoxide choline (diazoxide choline)

Snippet

Sponsor: Essentialis, Inc. | Conditions: Hypertriglyceridemia | Phase 1 | Status: WITHDRAWN